Published in J Virol on May 01, 1996
Placement of the structural proteins in Sindbis virus. J Virol (2002) 2.81
Structural changes of envelope proteins during alphavirus fusion. Nature (2010) 2.32
Electrostatic origin of the genome packing in viruses. Proc Natl Acad Sci U S A (2006) 1.81
Packaging signals in alphaviruses. J Virol (1997) 1.76
A structural and functional perspective of alphavirus replication and assembly. Future Microbiol (2009) 1.72
Membrane proteins organize a symmetrical virus. EMBO J (2000) 1.67
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
In vitro assembly of alphavirus cores by using nucleocapsid protein expressed in Escherichia coli. J Virol (1999) 1.54
Alphavirus nucleocapsid protein contains a putative coiled coil alpha-helix important for core assembly. J Virol (2001) 1.46
Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J Virol (1997) 1.42
Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. J Virol (1996) 1.28
Nucleic acid-dependent cross-linking of the nucleocapsid protein of Sindbis virus. J Virol (2000) 1.25
Preformed cytoplasmic nucleocapsids are not necessary for alphavirus budding. EMBO J (1996) 1.19
Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C. J Virol (2003) 1.15
Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions. J Virol (1997) 1.15
Catalytic core of alphavirus nonstructural protein nsP4 possesses terminal adenylyltransferase activity. J Virol (2006) 1.13
Essential amino acids of the hantaan virus N protein in its interaction with RNA. J Virol (2005) 1.13
Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization. Elife (2013) 1.10
Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution. J Virol (2011) 1.10
Identification of a bovine coronavirus packaging signal. J Virol (2000) 1.09
Deletions in the transmembrane domain of a sindbis virus glycoprotein alter virus infectivity, stability, and host range. J Virol (2003) 1.07
Alphavirus capsid protein helix I controls a checkpoint in nucleocapsid core assembly. J Virol (2006) 1.01
Role of sindbis virus capsid protein region II in nucleocapsid core assembly and encapsidation of genomic RNA. J Virol (2008) 0.98
Molecular links between the E2 envelope glycoprotein and nucleocapsid core in Sindbis virus. J Mol Biol (2011) 0.98
A heterologous coiled coil can substitute for helix I of the Sindbis virus capsid protein. J Virol (2003) 0.98
Dual roles for an arginine-rich motif in specific genome recognition and localization of viral coat protein to RNA replication sites in flock house virus-infected cells. J Virol (2009) 0.96
Replication of alphaviruses: a review on the entry process of alphaviruses into cells. Adv Virol (2011) 0.96
Role for conserved residues of sindbis virus nonstructural protein 2 methyltransferase-like domain in regulation of minus-strand synthesis and development of cytopathic infection. J Virol (2008) 0.96
Mutations in the endodomain of Sindbis virus glycoprotein E2 define sequences critical for virus assembly. J Virol (2006) 0.95
Sindbis virus nucleocapsid assembly: RNA folding promotes capsid protein dimerization. RNA (2004) 0.95
Interactions of the cytoplasmic domain of Sindbis virus E2 with nucleocapsid cores promote alphavirus budding. J Virol (2011) 0.90
Mutating conserved cysteines in the alphavirus e2 glycoprotein causes virus-specific assembly defects. J Virol (2012) 0.89
Bovine viral diarrhea virus core is an intrinsically disordered protein that binds RNA. J Virol (2007) 0.87
Role of conserved cysteines in the alphavirus E3 protein. J Virol (2008) 0.87
Venezuelan equine encephalitis virus nsP2 protein regulates packaging of the viral genome into infectious virions. J Virol (2013) 0.86
Directed evolution of a virus exclusively utilizing human epidermal growth factor receptor as the entry receptor. J Virol (2013) 0.84
Alphavirus genome delivery occurs directly at the plasma membrane in a time- and temperature-dependent process. J Virol (2013) 0.84
Heterologous production, purification and characterization of enzymatically active Sindbis virus nonstructural protein nsP1. Protein Expr Purif (2011) 0.83
Functional characterization of the Sindbis virus E2 glycoprotein by transposon linker-insertion mutagenesis. Virology (2007) 0.83
The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains. J Virol (2013) 0.82
Fusion of mApple and Venus fluorescent proteins to the Sindbis virus E2 protein leads to different cell-binding properties. Virus Res (2013) 0.82
Location and role of free cysteinyl residues in the Sindbis virus E1 and E2 glycoproteins. J Virol (2007) 0.81
Fluorescent Protein-Tagged Sindbis Virus E2 Glycoprotein Allows Single Particle Analysis of Virus Budding from Live Cells. Viruses (2015) 0.80
The alphavirus E3 glycoprotein functions in a clade-specific manner. J Virol (2012) 0.79
Crystallization, high-resolution data collection and preliminary crystallographic analysis of Aura virus capsid protease and its complex with dioxane. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.79
Crystal structure of aura virus capsid protease and its complex with dioxane: new insights into capsid-glycoprotein molecular contacts. PLoS One (2012) 0.78
trans-Protease activity and structural insights into the active form of the alphavirus capsid protease. J Virol (2014) 0.78
Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay. Sci Rep (2015) 0.77
Short self-interacting N-terminal region of rubella virus capsid protein is essential for cooperative actions of capsid and nonstructural p150 proteins. J Virol (2014) 0.76
The SD1 Subdomain of Venezuelan Equine Encephalitis Virus Capsid Protein Plays a Critical Role in Nucleocapsid and Particle Assembly. J Virol (2015) 0.75
Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design. MBio (2017) 0.75
A novel system for visualizing alphavirus assembly. J Virol Methods (2015) 0.75
Spatial and Temporal Analysis of Alphavirus Replication and Assembly in Mammalian and Mosquito Cells. MBio (2017) 0.75
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins. Proc Natl Acad Sci U S A (1981) 6.08
In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol (1991) 6.02
Icosahedral RNA virus structure. Annu Rev Biochem (1989) 5.65
Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (1991) 4.24
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
The capsid protein of Semliki Forest virus has clusters of basic amino acids and prolines in its amino-terminal region. Proc Natl Acad Sci U S A (1980) 3.26
Western equine encephalitis virus is a recombinant virus. Proc Natl Acad Sci U S A (1988) 3.19
Mutagenesis of the in-frame opal termination codon preceding nsP4 of Sindbis virus: studies of translational readthrough and its effect on virus replication. J Virol (1989) 2.59
Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology (1991) 2.57
Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J Virol (1994) 2.47
Mutagenesis of the 3' nontranslated region of Sindbis virus RNA. J Virol (1990) 2.42
Ross River virus 26 s RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins. Virology (1983) 2.38
Evidence for an autoprotease activity of sindbis virus capsid protein. Virology (1978) 2.34
Sequence analysis of three Sindbis virus mutants temperature-sensitive in the capsid protein autoprotease. Proc Natl Acad Sci U S A (1985) 2.18
Site-directed mutagenesis of the proposed catalytic amino acids of the Sindbis virus capsid protein autoprotease. J Virol (1990) 2.11
Complete sequence of the genomic RNA of O'nyong-nyong virus and its use in the construction of alphavirus phylogenetic trees. Virology (1990) 2.03
Deletion analysis of the capsid protein of Sindbis virus: identification of the RNA binding region. J Virol (1993) 2.03
Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins. Virology (1986) 1.84
Nucleotide sequence of the genome region encoding the 26S mRNA of eastern equine encephalomyelitis virus and the deduced amino acid sequence of the viral structural proteins. J Gen Virol (1987) 1.65
Role of ribosomes in Semliki Forest virus nucleocapsid uncoating. J Virol (1992) 1.51
Refined structure of Sindbis virus core protein and comparison with other chymotrypsin-like serine proteinase structures. J Mol Biol (1993) 1.49
Identification of a sequence element in the alphavirus core protein which mediates interaction of cores with ribosomes and the disassembly of cores. Virology (1992) 1.44
Budding of alphaviruses. Trends Microbiol (1995) 1.40
Structure-function relation of the NH2-terminal domain of the Semliki Forest virus capsid protein. J Virol (1995) 1.38
The mass of the Sindbis virus nucleocapsid suggests it has T = 4 icosahedral symmetry. Virology (1992) 1.37
Identification of a transfer of viral core protein to cellular ribosomes during the early stages of alphavirus infection. Virology (1984) 1.29
Kinetics of formation of the Semliki Forest virus nucleocapsid. Intervirology (1973) 1.26
Primary structures of the core proteins of the alphaviruses Semliki Forest virus and Sindbis virus. Virology (1981) 1.22
Subgenomic mRNA of Aura alphavirus is packaged into virions. J Virol (1994) 1.21
Aura virus is a New World representative of Sindbis-like viruses. Virology (1995) 1.20
Evidence for a change in capsid morphology during Sindbis virus envelopment. Virus Res (1984) 1.18
Biological activity of in vitro synthesised protein: binding of Semliki Forest virus capsid protein to the large ribosomal subunit. Biochem Biophys Res Commun (1976) 1.08
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58
Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24
A source of error in phenylketonuria screening. Am J Clin Pathol (1988) 2.59
Sindbis virus RNA polymerase is degraded by the N-end rule pathway. Proc Natl Acad Sci U S A (1991) 2.52
Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J Virol (1994) 2.47
Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure (1996) 2.46
High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol (1992) 2.44
Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol (1993) 1.95
Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol (2001) 1.91
Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy. Proc Natl Acad Sci U S A (1995) 1.81
Antiidiotypic antibodies as probes for the Sindbis virus receptor. Virology (1991) 1.72
Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg. J Virol (1990) 1.69
Alphavirus budding is dependent on the interaction between the nucleocapsid and hydrophobic amino acids on the cytoplasmic domain of the E2 envelope glycoprotein. Virology (1997) 1.61
In vitro assembly of alphavirus cores by using nucleocapsid protein expressed in Escherichia coli. J Virol (1999) 1.54
Alphavirus nucleocapsid protein contains a putative coiled coil alpha-helix important for core assembly. J Virol (2001) 1.46
An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety. J Virol (2001) 1.45
Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol (2009) 1.43
Human rhinovirus 3 at 3.0 A resolution. Structure (1996) 1.42
Budding of alphaviruses. Trends Microbiol (1995) 1.40
Molecular events leading to picornavirus genome replication. J Cell Sci Suppl (1987) 1.30
Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1. J Virol (2001) 1.27
Nucleic acid-dependent cross-linking of the nucleocapsid protein of Sindbis virus. J Virol (2000) 1.25
Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion event. J Virol (1993) 1.24
Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis. J Mol Biol (1996) 1.16
Expression of the poliovirus genome from infectious cDNA is dependent upon arrangements of eukaryotic and prokaryotic sequences in recombinant plasmids. Virology (1987) 1.15
In vitro assembly of Sindbis virus core-like particles from cross-linked dimers of truncated and mutant capsid proteins. J Virol (2001) 1.13
Cell recognition and entry by rhino- and enteroviruses. Virology (2000) 1.03
Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J Virol (2001) 1.02
Observations on the anatomy of the rectovaginal pouch and septum. Obstet Gynecol (1982) 1.02
Detection of membrane protein two-dimensional crystals in living cells. Biophys J (2011) 0.98
Pharmacokinetics of anti-infective agents in paediatric patients. Clin Pharmacokinet (1994) 0.96
Probing the potential glycoprotein binding site of sindbis virus capsid protein with dioxane and model building. Proteins (1998) 0.96
Uridylylation of the genome-linked protein of poliovirus in vitro is dependent upon an endogenous RNA template. Virus Res (1987) 0.95
Will the polio niche remain vacant? Dev Biol (Basel) (2001) 0.95
Active transport of nitrofurantoin into human milk. Pharmacotherapy (2001) 0.93
Protein kinase G phosphorylates mosquito-borne flavivirus NS5. J Virol (2009) 0.90
Active transport of cimetidine into human milk. Clin Pharmacol Ther (1995) 0.90
Genetic and biochemical studies on the assembly of an enveloped virus. Genet Eng (N Y) (2001) 0.90
Molecular events leading to poliovirus genome replication. Cold Spring Harb Symp Quant Biol (1987) 0.88
Pharmacokinetics of netilmicin in premature infants. Eur J Clin Pharmacol (1986) 0.88
Bacterial contamination of aerosol solutions used to treat cystic fibrosis. Am J Hosp Pharm (1982) 0.87
Choriocarcinoma coexistent with intrauterine pregnancy. Aust N Z J Obstet Gynaecol (1980) 0.87
Cardiorespiratory effects of premedication for children. Anesth Analg (1995) 0.86
Host-cell receptors for Sindbis virus. Arch Virol Suppl (1994) 0.86
Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Ann Pharmacother (1997) 0.84
Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. Pediatr Infect Dis J (1997) 0.84
Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br J Clin Pharmacol (1995) 0.84
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. Pediatr Infect Dis J (1997) 0.83
Methemoglobinemia induced by an over-the-counter medication. Ann Pharmacother (1996) 0.82
Susceptibility of pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis. Pharmacotherapy (2001) 0.82
Vault haematoma after vaginal hysterectomy: an invariable sequel? Aust N Z J Obstet Gynaecol (1985) 0.81
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. Ann Pharmacother (1997) 0.81
A double blind trial of extra-amniotic oestriol and prostaglandin F2 alpha gels in cervical ripening. Br J Obstet Gynaecol (1981) 0.80
Skin discoloration with blue food coloring. Ann Pharmacother (2001) 0.80
Betamethasone, albuterol, and threatened premature delivery: benefits and risks. Study of 469 pregnancies. Obstet Gynecol (1982) 0.79
Virology. When it's better to lie low. Nature (1995) 0.79
Pancreatic enzyme therapy in patients with cystic fibrosis: the high dose lipase issue. Pediatr Nurs (1995) 0.77
Control of anterior vertical dimension and proper selection of extraoral anchorage. Angle Orthod (1968) 0.77
Therapeutic management of cystic fibrosis. Clin Pharm (1985) 0.76
Suggested change to the transfer case protocol. Am J Orthod Dentofacial Orthop (1995) 0.75
Triplet pregnancy and Rhesus isoimmunization. Med J Aust (1977) 0.75
Vasoactivity generated from platelets by immune complexes in pre-eclampsia. Clin Exp Pharmacol Physiol (1983) 0.75
Management of ovarian remnant syndrome. Aust N Z J Obstet Gynaecol (1996) 0.75
Compatibility of 10% sodium benzoate plus 10% sodium phenylacetate with various flavored vehicles. Am J Hosp Pharm (1994) 0.75
Photobiological properties of positively charged methylene violet analogs. Photochem Photobiol (2000) 0.75
Clinical implications of catheter variability on neonatal continuous arteriovenous hemofiltration. ASAIO Trans (1988) 0.75
Retrospective audit of cefuroxime use in pediatric patients. Am J Hosp Pharm (1988) 0.75
High-dose lorazepam therapy for status epilepticus in a pediatric patient. Drug Intell Clin Pharm (1988) 0.75
Pharmacologic management of cystic fibrosis. Clin Pharm (1993) 0.75
Do we know what we are really looking for? Am J Hosp Pharm (1991) 0.75
Non-stress antenatal cardiotocography in high risk pregnancy. Asia Oceania J Obstet Gynaecol (1982) 0.75
Chemoprophylaxis with tinidazole in major gynaecological surgery. Aust N Z J Obstet Gynaecol (1980) 0.75
Pediatric asthma update: current therapy and new agents. Pediatr Nurs (1997) 0.75
Immune complexes and vasoactivity generated from platelets in pre-eclampsia. Clin Exp Hypertens B (1982) 0.75
Intrapartum fetal intensive care: 2-year experience. Aust N Z J Obstet Gynaecol (1981) 0.75
Permeability decay in CAVH hemofilters. ASAIO Trans (1989) 0.75
Stability of netilmicin sulfate in admixtures with calcium gluconate and aminophylline. Am J Hosp Pharm (1986) 0.75
Infection rates in adult and pediatric inpatients when i.v. sets are changed every 72 hours. Am J Hosp Pharm (1994) 0.75
Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation. Transpl Infect Dis (2011) 0.75
Treating the asthmatic child with dry powder inhalers: a possible breakthrough. Pediatr Nurs (2002) 0.75
Abnormal antepartum cardiotocography and major fetal abnormalities. Aust N Z J Obstet Gynaecol (1986) 0.75
Pulmozyme--Dornase alfa. Pediatr Nurs (1994) 0.75